- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01013467
CoCo: Colour Coded Blood Pressure Control (CoCo)
Does a Colour-coded Blood Pressure Diary Improve Blood Pressure Control for Patients in General Practice? A Randomised Controlled Study
Insufficient blood pressure control is a frequent problem despite the existence of effective treatment. One of the causes is insufficient self-monitoring and a lack of adherence to therapy. Blood pressure self-measurement at home (Home Blood Pressure Measurement, HBPM) has positive effects on treatment adherence and is helpful in achieving the target blood pressure.
Only a few studies have investigated whether the adherence for HBPM can be improved through simple measures and better blood pressure monitoring can be achieved.
Objective Improvement of self-monitoring by means of blood pressure self-measurement and improved blood pressure control by using a new colour-coded blood pressure diary
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8091
- University Hospital Zurich, Institute of General Practice
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Age >18 years
- BP > 140/90 mmHg Two consecutive measurements carried out in the practice (measured by the general practitioner at the start of the study).
- Unchanged anti-hypertension treatment for one month before inclusion
- Patient able to measure blood pressure at home
- Written informed consent
Exclusion criteria: • Blood pressure reading over 180 mmHg systolic and/or 110 mmHg diastolic.
- Serious general or psychological illness (malignant tumor, serious depressive episodes or evidence of dementia).
- Insufficient knowledge of the German language for instruction and blood pressure recording with a booklet.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: color coded bloodpressure booklet
|
The patients in the intervention group will receive a colour-coded blood pressure record booklet.
The corresponding colour coded areas are divided into three areas of green, yellow and red following a traffic light system.
The green area covers blood pressure readings up to a maximum of 140/90 mmHg, the yellow area includes systolic readings over 140 to 180 mm Hg and diastolic readings over 90 to 110 mmHg.
The red area covers systolic readings over 180 mmHg and diastolic readings over 110 mmHg.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Primary outcome: change in systolic and/or diastolic blood pressure 6 months after using the new colour-coded blood pressure diary.
Time Frame: 6months
|
6months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
adherence with home blood pressure measurements
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas J. Rosemann, Prof MD, University Hospital Zurich, Institute of General Practice
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1738
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on "CoCo" colour coded blood pressure control
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingMonotherapy | Hypertensive PatientsChina
-
University of California, San FranciscoTerminatedPilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD (PERFORMANCE)Hypertension | Chronic Kidney Disease | BloodpressureUnited States
-
University of California, San FranciscoCompletedHypertension | Chronic Kidney Diseases | Blood PressureUnited States
-
Vanderbilt University Medical CenterSarah Osmundson, MD, MS; Alex Phelps, MD; Julia Phillippi, PhD, CNM; Soha Patel... and other collaboratorsCompletedHypertension, Pregnancy-Induced | Postpartum Preeclampsia | Hypertension; MaternalUnited States
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS)Completed
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiopulmonary Bypass | Thoracic SurgeryUnited States
-
University of California, IrvineRecruiting
-
Takeshi MorimotoTerminatedCoronary Artery Disease | HypertensionJapan
-
Rutgers, The State University of New JerseyCompleted
-
Asan Medical CenterPfizerTerminatedBrain IschemiaKorea, Republic of